Tipifarnib-mediated suppression of T-bet-dependent signaling pathways.
Bai F, Villagra AV, Zou J, Painter JS, Connolly K, Blaskovich MA, Sokol L, Sebti S, Djeu JY, Loughran TP, Wei S, Sotomayor E, Epling-Burnette P.
Bai F, et al. Among authors: sebti s.
Cancer Immunol Immunother. 2012 Apr;61(4):523-33. doi: 10.1007/s00262-011-1109-0. Epub 2011 Oct 9.
Cancer Immunol Immunother. 2012.
PMID: 21983879
Free PMC article.